We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Optibiotix Health Plc | LSE:OPTI | London | Ordinary Share | GB00BP0RTP38 | ORD 2P |
| Price Change | % Change | Share Price | Shares Traded | Last Trade
|
|
|---|---|---|---|---|---|
| 0.00 | 0.00% | 18.25 | 11,416 | 08:00:00 |
| Bid Price | Offer Price | High Price | Low Price | Open Price | |
|---|---|---|---|---|---|
| 17.50 | 19.00 | 18.25 | 18.25 | 18.25 | |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Noncomml Resh Organizations | 644k | -2.04M | -0.0208 | -8.77 | 17.87M |
| Last Trade Time | Trade Type | Trade Size | Trade Price | Currency |
|---|---|---|---|---|
| 16:21:55 | O | 985 | 17.675 | GBX |
| Date | Time | Source | Headline |
|---|---|---|---|
| 20/5/2025 | 21:45 | ALNC |  TRADING UPDATES: GetsBusy backs sales outlook; Cizzle raises funds |
| 20/5/2025 | 07:00 | UK RNS | OptiBiotix Health PLC Launch of SlimBiome products with US partner |
| 15/4/2025 | 07:00 | UK RNS | OptiBiotix Health PLC First order from US weight management brand |
| 07/4/2025 | 17:34 | UK RNS | SkinBioTherapeutics PLC Holding(s) in Company |
| 18/3/2025 | 07:00 | UK RNS | OptiBiotix Health PLC Commercial Update |
| 18/2/2025 | 07:00 | UK RNS | OptiBiotix Health PLC Launch of Daily Nouri FeelFull product in America |
| 20/1/2025 | 07:00 | UK RNS | OptiBiotix Health PLC Launch of products on Amazon India |
| 13/1/2025 | 14:59 | ALNC | EXECUTIVE CHANGES: Various Eateries hires Young's executive as CEO |
| 08/1/2025 | 07:00 | UK RNS | OptiBiotix Health PLC Directorate Change |
| 20/12/2024 | 12:00 | UK RNS | OptiBiotix Health PLC Issue of Options |
Optibiotix Health (OPTI) Share Charts1 Year Optibiotix Health Chart |
|
1 Month Optibiotix Health Chart |
Intraday Optibiotix Health Chart |
| Date | Time | Title | Posts |
|---|---|---|---|
| 21/5/2025 | 13:44 | OptiBiotix Health PLC - | 19,228 |
| 21/5/2025 | 08:02 | OptiBiotix - The uncensored thread | 67,968 |
| 11/3/2025 | 15:04 | OptiBiotix - Better Science, Better Health. Better buy some! | 58,178 |
| 06/2/2025 | 12:14 | Optibiotix. The Company that always promises but never delivers. | 23 |
| 14/11/2024 | 16:51 | OptiBiotix Health (Facts NOT Fiction) | 5,390 |
| Trade Time | Trade Price | Trade Size | Trade Value | Trade Type |
|---|---|---|---|---|
| 15:21:56 | 17.68 | 985 | 174.10 | O |
| 15:12:05 | 17.68 | 967 | 170.92 | O |
| 14:30:41 | 17.68 | 114 | 20.15 | O |
| 13:35:21 | 17.50 | 3,758 | 657.65 | O |
| 11:01:10 | 18.35 | 5,384 | 987.96 | O |
| Top Posts |
|---|
Posted at 22/5/2025 09:20 by Optibiotix Health Daily Update Optibiotix Health Plc is listed in the Noncomml Resh Organizations sector of the London Stock Exchange with ticker OPTI. The last closing price for Optibiotix Health was 18.25p.Optibiotix Health currently has 97,943,161 shares in issue. The market capitalisation of Optibiotix Health is £17,874,627. Optibiotix Health has a price to earnings ratio (PE ratio) of -8.77. This morning OPTI shares opened at 18.25p |
Posted at 20/5/2025 11:41 by the gerbilator Only problem is that no sign of maker having prepped an share price walk-up into the RNS.i might wait for a better buy price -50p |
Posted at 19/5/2025 20:51 by the gerbilator Letter to AIM Regulation & the FCA:Investigate Neil Davidson or others at Optibiotix Someone at Optibiotix (OPTI) may have breached AIM Rule 10 and possibly committed fraud...} ........ Oh no. Everyone will be calling TW a mad knut now and targeting him daily |
Posted at 16/5/2025 20:26 by the gerbilator Subject: OPTI Plc - Signs of Distribution and Potential ManipulationThe recent price action in OPTI Plc is raising several red flags that suggest a concerted effort to offload positions under the guise of maintaining a stable structure. The market is exhibiting classic signs of distribution, with large blocks being sold at or near key resistance levels while liquidity is systematically drained from lower levels. This pattern is indicative of institutional sellers masking their exits as ordinary market activity, effectively trapping retail participants in a deteriorating structure. Interestingly, much of the selling pressure may not be immediately visible on the Level 2 Book. The use of hidden orders, iceberg orders, and dark pool transactions can effectively conceal the scale of distribution underway. This aligns with the observed flow dynamics — large blocks being offloaded without corresponding buy-side support, suggesting that the real intent is being masked behind passive or layered orders. What is keeping price from collapsing into voids is a calculated effort to maintain appearances. Institutions can prop up price temporarily with passive buy programs, strategically placing layered orders that absorb just enough selling to prevent a complete breakdown. Simultaneously, algorithmic systems are likely operating in the background, managing liquidity to avoid tipping their hand prematurely. Additionally, sellers may intentionally refrain from pressing price lower too quickly. By holding price above voids, they can create a false sense of stability, drawing in more unsuspecting buyers and trapping them in the process. This controlled distribution tactic serves to maximize selling at favourable levels before the eventual breakdown occurs. The liquidity landscape is a stark warning signal. Large voids have opened below current levels, creating an environment where trapped longs will struggle to exit without exacerbating the downside momentum. The absence of institutional bids at key levels further suggests that major players are in no rush to absorb the selling pressure, opting instead to let the market fall through thin liquidity zones. Flow dynamics.....} They get into full detail on OPTI market after this point so wont bore you all with that. |
Posted at 13/5/2025 19:04 by the gerbilator PGlancyPosts: 415 Price: 20.00 No Opinion RE: TEENSToday 10:53 SOH lied about what happened. He allowed himself to be suckered for the same trick by cavendish as he did with share price angel. He also assured tw he would not be selling below 40p then revised to 35p. Oh wait under 25p was it. How can investors trust a ceo that willingly decieve investors and people like tw that constantly ramps opti. I thought tw hated liars. ............. Depends. Might be an article about you now that you called SoH one haha 'SOH lied about what happened. He allowed himself to be suckered...] Only ones getting suckered are those that think he got suckered |
Posted at 12/5/2025 15:55 by the gerbilator Well, I'm not asking you to believe anything other than share price since august 2018 lol. Maybe that is lying as well - maybe not. Truth in the sell price i suspect |
Posted at 19/4/2025 22:11 by the gerbilator Retatrutide is a big threat, as can be seen in the panic share price here for escape haha. Albeit a big threat to what i do not know. Smaller losses? |
Posted at 07/12/2024 08:53 by pj 1 If they do need funds hence the selling in Skin then SOH has some serious explaining to doFrom the Palcing in March, just £1.3m! OptiBiotix Health PLC 25 March 2024 OptiBiotix Health plc ("OptiBiotix" or the "Company") Placing, Subscription and Director Dealing OptiBiotix Health plc (AIM: OPTI), a life sciences business developing compounds to tackle obesity, cardiovascular disease, diabetes and skincare, announces it has raised in aggregate £1,350,500 through the issue of 6,752,500 new ordinary shares of 2 pence each in the Company ("Fundraise Shares") at a price of 20 pence per share ("Issue Price") (together, the "Fundraise") handled by Peterhouse Capital Limited. The Fundraise comprises a placing of 6,627,500 new ordinary shares at the Issue Price, raising gross proceeds of £1,325,500 (the "Placing") and a subscription for 125,000 new ordinary shares at the Issue Price, raising gross proceeds of £25,000, by Graham Myers, a director of the Company (the "Subscription"). Following the Subscription, Graham Myers will be interested in 125,000 ordinary shares in the Company, representing 0.13 per cent. of the Company's issued share capital following Admission (as defined below). The net proceeds of the Fundraise will be utilised to invest in driving sales growth by:- 1. active account management of existing partners by co-investing in publicity, marketing, and promotions to increase sales; 2. increased presence of the Company's stands at major exhibitions to attract new partners, particularly in the USA and India to mitigate dependency on a small number of partners; 3. investing in marketing the Company's products to grow sales on e-commerce platforms in India, China, USA, Europe, and the Gulf States; and 4. launch its second generation SweetBiotix and MicroBiome Modulator products. The word co-invest was used, so its not for Morepen, hes al;ready raised for sweetbiotox but delivered nothing so those funds must still be here. So, key question, IF it is OPTI reducing then what the hell for? |
Posted at 26/10/2024 19:44 by putinaire 2017OptiBiotix Health plc (AIM: OPTI), a life sciences business developing compounds to tackle obesity, high cholesterol, diabetes and skin care, announces it plans to launch products containing its cholesterol reducing strain (LPLDL®) at the Vitafoods Europe Trade Show ("Vitafoods") in Geneva on the 9-11 May 2017. The trade show provides opportunities to connect with 16,500 industry decision makers from the supplements, nutraceutical, functional food and beverage industries. The event is viewed as one of the world's leading trade fairs for the food and drinks industry ............... OptiBiotix Health plc (AIM: OPTI), a life sciences business developing compounds to tackle obesity, high cholesterol, diabetes and skin care, announces that it has agreed to grant a non-exclusive license agreement to Nutrilinea for the production and commercialisation of products containing OptiBiotix's LPLDL® strain in Europe with a view to maximising the financial return for both parties. .............. OptiBiotix Health plc (AIM: OPTI), a life sciences business developing compounds to tackle obesity, high cholesterol, diabetes and skin care, announces that HLH BioPharma Vertriebs GmbH ("HLH") have achieved product registration of LPLDL® capsules at IFA GmbH and "Bundesamt für Lebensmittelsicherhe ............... OptiBiotix Health plc (AIM: OPTI), a life sciences business developing compounds to tackle obesity, high cholesterol, diabetes and skin care, announces that it has entered into a three year supply agreement with Galenicum Special Ingredients, S.L ("Galenicum") to commercialise products containing OptiBiotix's cholesterol and blood pressure reducing strain, LPLDL®. The agreement grants Galenicum a non-exclusive license to commercialise Cardiocare™, a nutritional supplement containing OptiBiotix's LPLDL® in Spain, Chile, Peru and the Middle East with the aim of maximising the financial return for both parties. .............. 2018 OptiBiotix Health plc (AIM: OPTI), a life sciences business developing compounds to tackle obesity, high cholesterol, diabetes and skin care, announces that it has entered into a production and commercialisation agreement with Fine Foods & Pharmaceuticals N.T.M. S.p.A ("Fine Foods"). The agreement grants Fine Foods an exclusive license for the production and supply of five formulations containing OptiBiotix's LPLDL® strain in Europe in return for royalty payments and a commitment to maximising the financial return for both parties. ............ OptiBiotix Health plc (AIM: OPTI), a life sciences business developing compounds to tackle obesity, high cholesterol, diabetes and skin care, announces it has entered into license agreement with ALFASIGMA S.p.A. ("ALFASIGMA") to exclusively commercialise food supplements containing OptiBiotix's cholesterol and blood pressure reducing LPLDL® strain in Italy. ......... |
Posted at 24/10/2024 09:41 by putinaire OPTI RNS recently, included advice to PBX[... OptiBiotix advised of its recent successful fundraise of £1.35m by the Company and identified lack of market communication by Mr Andersen as the main reason for the failed PBX fundraise. OptiBiotix requested that PBX increase its news flow to potentially support the share price and build positive investor sentiment ...] Did they advise SBTX yesterday too? So more could be sold? |
Posted at 18/10/2024 09:16 by kreature ‘ OptiBiotix requested that PBX increase its news flow to potentially support the share price ’So was the idea to manipulate the share price with news ? What news ? Very confusing RNS. How would Opti know if there were any unreleased news ? |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
.png){kind=logo}
